Literature DB >> 31191303

Corrigendum: Berberine Improves Benign Prostatic Hyperplasia via Suppression of 5 Alpha Reductase and Extracellular Signal-Regulated Kinase in Vivo and in Vitro.

Dong-Hyun Youn1,2, Jinbong Park1,2, Hye-Lin Kim1, Yunu Jung1,2, JongWook Kang1,2, Seona Lim1,2, Gahee Song1,2, Hyun Jeong Kwak1, Jae-Young Um1,2.   

Abstract

[This corrects the article DOI: 10.3389/fphar.2018.00773.].

Entities:  

Keywords:  5 alpha reductase; androgen receptor; benign prostatic hyperplasia; berberine; extracellular signal-regulated kinase; mitogen-activated protein kinase

Year:  2019        PMID: 31191303      PMCID: PMC6539197          DOI: 10.3389/fphar.2019.00541

Source DB:  PubMed          Journal:  Front Pharmacol        ISSN: 1663-9812            Impact factor:   5.810


  2 in total

1.  Phytosterols in hull-less pumpkin seed oil, rich in ∆7-phytosterols, ameliorate benign prostatic hyperplasia by lowing 5α-reductase and regulating balance between cell proliferation and apoptosis in rats.

Authors:  Xin-Cong Kang; Tian Chen; Jia-Li Zhou; Peng-Yuan Shen; Si-Hui Dai; Chang-Qing Gao; Jia-Yin Zhang; Xing-Yao Xiong; Dong-Bo Liu
Journal:  Food Nutr Res       Date:  2021-12-02       Impact factor: 3.894

2.  Oral administration of berberine represses macrophage activation-associated benign prostatic hyperplasia: a pivotal involvement of the NF-κB.

Authors:  Bo-Ram Jin; Hyo-Jin An
Journal:  Aging (Albany NY)       Date:  2021-08-19       Impact factor: 5.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.